TY - JOUR AU - Siegal, D. M. AU - Garcia, D. A. AU - Crowther, M. A. PY - 2014 DA - 2014// TI - How I treat target-specific oral anticoagulant-associated bleeding JO - Blood. VL - 123 UR - https://doi.org/10.1182/blood-2013-09-529784 DO - 10.1182/blood-2013-09-529784 ID - Siegal2014 ER - TY - JOUR AU - Pollack, C. V. AU - Reilly, P. A. AU - Ryn, J. AU - Eikelboom, J. W. AU - Glund, S. AU - Bernstein, R. A. PY - 2017 DA - 2017// TI - Idarucizumab for dabigatran reversal — full cohort analysis JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1707278 DO - 10.1056/NEJMoa1707278 ID - Pollack2017 ER - TY - JOUR AU - Siegal, D. AU - Lu, G. AU - Leeds, J. M. AU - Karbarz, M. AU - Castillo, J. AU - Mathur, V. PY - 2017 DA - 2017// TI - Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa JO - Blood Adv VL - 1 UR - https://doi.org/10.1182/bloodadvances.2017007112 DO - 10.1182/bloodadvances.2017007112 ID - Siegal2017 ER - TY - JOUR AU - Connolly, S. J. AU - Milling, T. J. AU - Eikelboom, J. W. AU - Gibson, C. M. AU - Curnutte, J. T. AU - Gold, A. PY - 2016 DA - 2016// TI - Andexanet alfa for acute major bleeding associated with factor Xa inhibitors JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1607887 DO - 10.1056/NEJMoa1607887 ID - Connolly2016 ER - TY - JOUR AU - Sauter, T. C. AU - Eberle, B. AU - Wuillemin, W. A. AU - Thiele, T. AU - Angelillo-Scherrer, A. AU - Exadaktylos, A. K. PY - 2018 DA - 2018// TI - How I manage patients with anticoagulation-associated bleeding or urgent surgery JO - Swiss Med Wkly VL - 148 ID - Sauter2018 ER - TY - JOUR AU - Frontera, J. A. AU - Lewin, J. J. AU - Rabinstein, A. A. AU - Aisiku, I. P. AU - Alexandrov, A. W. AU - Cook, A. M. PY - 2016 DA - 2016// TI - Guideline for reversal of Antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical care society and Society of Critical Care Medicine JO - Neurocrit Care VL - 24 UR - https://doi.org/10.1007/s12028-015-0222-x DO - 10.1007/s12028-015-0222-x ID - Frontera2016 ER - TY - STD TI - Heidbuchel H, Verhamme P, Alings M, Antz M, Diener H-C, Hacke W, et al. Updated European heart rhythm association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J. 2016:ehw058. ID - ref7 ER - TY - JOUR AU - Martin, A. -. C. AU - Bonniec, B. AU - Fischer, A. -. M. AU - Marchand-Leroux, C. AU - Gaussem, P. AU - Samama, C. -. M. PY - 2013 DA - 2013// TI - Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis JO - Int J Cardiol VL - 168 UR - https://doi.org/10.1016/j.ijcard.2013.07.152 DO - 10.1016/j.ijcard.2013.07.152 ID - Martin2013 ER - TY - JOUR AU - Shaw, J. R. AU - Castellucci, L. AU - Siegal, D. AU - Stiell, I. AU - Syed, S. AU - Lampron, J. PY - 2018 DA - 2018// TI - Management of direct oral anticoagulant associated bleeding: results of a multinational survey JO - Thromb Res VL - 163 UR - https://doi.org/10.1016/j.thromres.2018.01.008 DO - 10.1016/j.thromres.2018.01.008 ID - Shaw2018 ER - TY - JOUR AU - Hirsh, J. AU - Ginsberg, J. S. PY - 2018 DA - 2018// TI - Edoxaban for the treatment of venous thromboembolism in patients with Cancer JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMe1800041 DO - 10.1056/NEJMe1800041 ID - Hirsh2018 ER - TY - JOUR AU - Raskob, G. E. AU - Es, N. AU - Verhamme, P. AU - Carrier, M. AU - Nisio, M. AU - Garcia, D. PY - 2018 DA - 2018// TI - Edoxaban for the treatment of Cancer-associated venous thromboembolism JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1711948 DO - 10.1056/NEJMoa1711948 ID - Raskob2018 ER - TY - JOUR AU - Bekelis, K. AU - Chang, C. -. H. AU - Malenka, D. AU - Morden, N. E. PY - 2018 DA - 2018// TI - Direct oral anticoagulant and antiplatelet combination therapy: hemorrhagic events in coronary artery stent recipients JO - J Clin Neurosci VL - 50 UR - https://doi.org/10.1016/j.jocn.2018.01.004 DO - 10.1016/j.jocn.2018.01.004 ID - Bekelis2018 ER - TY - JOUR AU - Alexander, J. H. AU - Lopes, R. D. AU - James, S. AU - Kilaru, R. AU - He, Y. AU - Mohan, P. PY - 2011 DA - 2011// TI - Apixaban with antiplatelet therapy after acute coronary syndrome JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1105819 DO - 10.1056/NEJMoa1105819 ID - Alexander2011 ER - TY - JOUR AU - Oldgren, J. AU - Budaj, A. AU - Granger, C. B. AU - Khder, Y. AU - Roberts, J. AU - Siegbahn, A. PY - 2011 DA - 2011// TI - Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehr113 DO - 10.1093/eurheartj/ehr113 ID - Oldgren2011 ER - TY - JOUR AU - Mega, J. AU - Braunwald, E. AU - Mohanavelu, S. AU - Burton, P. AU - Poulter, R. AU - Misselwitz, F. PY - 2009 DA - 2009// TI - Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60738-8 DO - 10.1016/S0140-6736(09)60738-8 ID - Mega2009 ER - TY - JOUR AU - Rothberg, M. B. AU - Celestin, C. AU - Fiore, L. D. AU - Lawler, E. AU - Cook, J. R. PY - 2005 DA - 2005// TI - Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit JO - Ann Intern Med VL - 143 UR - https://doi.org/10.7326/0003-4819-143-4-200508160-00005 DO - 10.7326/0003-4819-143-4-200508160-00005 ID - Rothberg2005 ER - TY - JOUR AU - Desai, J. AU - Kolb, J. AU - Weitz, J. AU - Aisenberg, J. PY - 2013 DA - 2013// TI - Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies JO - Thromb Haemost VL - 110 UR - https://doi.org/10.1160/TH13-02-0150 DO - 10.1160/TH13-02-0150 ID - Desai2013 ER - TY - JOUR AU - Cheung, K. -. S. AU - Leung, W. K. PY - 2017 DA - 2017// TI - Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management JO - World J Gastroenterol VL - 23 UR - https://doi.org/10.3748/wjg.v23.i11.1954 DO - 10.3748/wjg.v23.i11.1954 ID - Cheung2017 ER - TY - JOUR AU - Sprigg, N. AU - Flaherty, K. AU - Appleton, J. P. AU - Salman, R. A. -. S. AU - Bereczki, D. AU - Beridze, M. PY - 2018 DA - 2018// TI - Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)31033-X DO - 10.1016/S0140-6736(18)31033-X ID - Sprigg2018 ER - TY - JOUR AU - Sauter, T. C. AU - Amylidi, A. -. L. AU - Ricklin, M. E. AU - Lehmann, B. AU - Exadaktylos, A. K. PY - 2016 DA - 2016// TI - Direct new oral anticoagulants in the emergency department: experience in everyday clinical practice at a Swiss university hospital JO - Eur J Intern Med VL - 29 UR - https://doi.org/10.1016/j.ejim.2015.12.009 DO - 10.1016/j.ejim.2015.12.009 ID - Sauter2016 ER - TY - JOUR AU - Sauter, T. C. AU - Blum, S. AU - Nagler, M. AU - Schlittler, F. L. AU - Ricklin, M. E. AU - Exadaktylos, A. K. PY - 2016 DA - 2016// TI - Reversal of dabigatran using Idarucizumab in a septic patient with impaired kidney function in real-life practice JO - Case Rep Emerg Med VL - 2016 UR - https://doi.org/10.1155/2016/1393057 DO - 10.1155/2016/1393057 ID - Sauter2016 ER - TY - JOUR AU - Chang, S. -. H. AU - Chou, I. -. J. AU - Yeh, Y. -. H. AU - Chiou, M. -. J. AU - Wen, M. -. S. AU - Kuo, C. -. T. PY - 2017 DA - 2017// TI - Association between use of non-vitamin K Oral anticoagulants with and without concurrent medications and risk of major bleeding in Nonvalvular atrial fibrillation JO - JAMA. VL - 318 UR - https://doi.org/10.1001/jama.2017.13883 DO - 10.1001/jama.2017.13883 ID - Chang2017 ER -